Omixon at the ASHG conference in Boston

26/10/2013

Omixon exhibited at the 63rd Annual Meeting of the American Society of Human Genetics that was held held at the Boston Convention & Exhibition Center (BCEC) in Boston, 22-26 October. The ASHG Annual Meeting is the largest human genetics meeting and exposition in the world.

Here is a photo we took with Tim Hague, our CEO in the middle, and Attila Bérces, Founder and Chairman on the left.

Twitter was on fire during the event by using the #ASHG2013 hashtag and the analytics of that hashtag demonstrated the real power this channel can have for communication about genetics as well. See our Twitter channel for more.

Flashcard Fridays – Personalized medicine

25/10/2013

One of the “big things” we hope to achieve in the near future with the help of next generation sequencing (and other modern laboratory and diagnostic methods) is personalized medicine. If you”re not familiar with the term, check out this Wikipedia article. Very briefly, personalized medicine (or PM) includes everything from drug selection to disease prevention strategies, it just has to be tailored to the needs of a specific patient.

Continue reading →

Flashcard Fridays – Another one bites the dust – Roche 454 shut down

18/10/2013

After shutting down all their NGS research programmes in April, Roche announced this week that they”re discontinuing the 454 sequencers. Although there are a lot of 454 sequencers in use all around the world and production/support will not completely stop until 2016, based on how fast SOLiD disappeared, 454 won”t be around very long. So, here are a few great articles, to commemorate a good, but commercially not viable sequencer Continue reading →

Upcoming webinar: HLA typing from whole exome and whole genome NGS data

14/10/2013

Broadcasting time & date: 6-7 PM CET, 31st October (Thursday)

Join us in an online presentation about HLA typing, especially from whole exome and whole genome next generation sequencing data.

REGISTER HERE

In this webinar you will learn about:

the importance of the HLA region in Pharmacogenomics and Disease Association Studies
how Omixon solves the challenges of HLA typing from NGS data
new economical opportunities of adding HLA typing to your portfolio

Our presenters will be Tim Hague, CEO and Craig Funnell, Director of Sales & Marketing of Omixon.

A live Q&A session will follow the presentation, offering you the opportunity to put forward your questions. After registering you will receive a confirmation email containing information about joining the Webinar.

Reserve your webinar seat here.

Omixon’s workshop at ASHG conference, Boston

14/10/2013

We are happy to announce that Omixon is exhibiting at the 63rd Annual Meeting of the American Society of Human Genetics that will be held at the Boston Convention & Exhibition Center (BCEC) in Boston, 22-26 October. The ASHG Annual Meeting is the largest human genetics meeting and exposition in the world. This year’s meeting is expected to attract over 6,500 scientific attendees. Visit us at booth No.1003.

During the conference, Omixon will also hold a scientific workshop titled “HLA Typing Using Next-Generation Sequencing“, 12.30-14.00 on 23rd October (Room 260, Level 2). Come and join our Founder and Chairman, Attila Berces in a presentation about the importance of HLA typing from NGS data. Tim Hague, CEO of Omixon, will show you how Omixon Target HLA typing brings value during the analysis and will give a short demonstration about the software.

If you would like to schedule a meeting with Omixon, contact: hajnalka.hejja@omixon.com